• Profile
Close

Penumbra consumption rates based on time-to-maximum delay and reperfusion status: A post hoc analysis of the DEFUSE 3 trial

Stroke Jun 27, 2021

Yaghi S, Raz E, Dehkharghani S, et al. - In this post hoc analysis of the DEFUSE 3 trial (The Endovascular Therapy Following Imaging Evaluation for Ischemic Stroke), researchers sought to assess penumbra consumption rates for time-to-maximum (T max) delays in patients with large vessel occlusion assessed between 6 and 16 hours from last known normal. The sample consisted of patients with an acute ischemic stroke due to anterior circulation occlusion within 6 to 16 hours of last known normal. One hundred forty-one patients were included in the study, with 68 remaining untreated. T max >10-s mismatch volume may contain large volumes of salvageable tissue in extended window endovascular thrombectomy patients, whereas nearly half the T max >6-s mismatch volume may remain viable in untreated patients at 24 hours.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay